Impax launches new products division

Impax also announced the appointments of Michael Nestor as divisional president reporting to Larry Hsu, president and CEO of IMPAX, and Suneel Gupta, as divisional chief scientific officer reporting to Mr Nestor.

Prior to joining Impax Pharmaceuticals, Mr Nestor was COO for Piedmont Pharmaceuticals in Greensboro, North Carolina. And Mr Gupta worked at Alza Corporation, a wholly-owned subsidiary of Johnson & Johnson, for nearly 20 years, where he was most recently responsible for strategic vision and execution of clinical R&D as senior vice president and distinguished research fellow.

Mr Hsu, said: “We have very high expectations for Impax Pharmaceuticals and its mission to add value for patients by bringing products in the CNS therapeutic category.”